This platform gives access to an expanded complementary determining region (CDR) diversity that allows for rapid discovery of antibodies against (i) therapeutically relevant epitopes, (ii ...

introduced MUNIS as a predictive framework capable of identifying CD8+ T cell epitopes with unprecedented accuracy. This breakthrough could streamline vaccine design for various infectious ...

Tharimmune (THAR) announced the expansion of its product pipeline with HS1940, a dual-target multispecific biologic engineered to bind to both ...

Tharimmune Inc. has applied its Epiclick multispecific antibody engineering platform to expand its pipeline. With Epiclick, the company can combine distinct antibody binding domains, including those ...